on 15 Dec 2020
Last Applicant/ Owned by
Suite G16,
AU
Serial Number
79276870 filed on 12th Sep 2019
Registration Number
6219009 registered on 15th Dec 2020
Filing Basis
No Filing Basis
Disclaimer
NO DATA
The mark consists of the following: the wording "SpeeDx" with the wording in black except for one diagonal line of the letter "X" which is blue. A stylized DNA strand of blue and purple is to the left of the wording. White is used for the background but is not claimed as a feature of the mark. Pharmaceutical and veterinary preparations and substances; biological chemical test kits comprised of reRead More
Chemical preparations used in industry, science, photography, agriculture, horticulture and forestry, except fungicides, herbicides, insecticides, and parasiticides; reagents and reactants for non-medical purposes; enzymes for industrial or scientific purposes; nucleic acid for other than medical and veterinary purposes; nucleic recombinant acids for other than medical and veterinary purposes; acids namely inorganic acids for industrial purposes; DNA polymerase; chemicals used in food processing and screening; chemicals used in environmental monitoring
Pharmaceutical and veterinary preparations and substances; biological chemical test kits comprised of reagents and assays for medical laboratory use in analysis that test for the presence of gene expression, protein expression, metabolite expression, inflammation, immune-suppression, immune disorders; reagents for medical and veterinary use; nucleic acid amplification reagents for medical use; nucleic acid sequencing programs for medical use; chemical preparations containing enzymes for medical purposes; chemical preparations containing enzymes for pharmaceutical, veterinary and medical purposes; enzymes for pharmaceutical, veterinary and medical purposes; medical kits containing medical and/or pharmaceutical preparations and associated detection reagents for the diagnosis of diseases, for detection and identification of pathogens, for the detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolite expression, inflammation, and immune-suppression and immune disorders, for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and analysis of epigenetic alterations, and for analysis of response to therapy; clinical diagnostics for medical or veterinary use
Surgical, medical and veterinary apparatus and instruments; medical and veterinary apparatus and instruments being diagnostic testing apparatus and instruments for medical purposes; diagnostic testing kits containing diagnostic testing apparatus; point of care medical devices; screening kits in this class consisting of medical screening and testing apparatus for the diagnosis of disease, detection and/or identification of pathogens, for the detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolic expression, inflammation, and immune-suppression and/or immune disorders for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and/or analysis of epigenetic alterations, analysis of response to therapy
Scientific and technological services and research and design relating thereto, namely, DNA analysis services for scientific research purposes, scientific research consulting in the field of genetics; laboratory analysis in the field of chemistry; development of diagnostic apparatus for genetics research; design of diagnostic apparatus for genetics research; research relating to molecular sciences; analysis of data generated by scientific and medical experiments and tests; biological, bacteriological, chemical, biochemical, dna, rna, protein, polynucleic acid and molecular analysis and evaluation services; dna and rna and polynucleic acid and protein sequencing, analysis and evaluation services; genome sequencing services and the analysis and evaluation of data resulting therefrom; scientific analysis and the provision of reports in conjunction therewith relating to scientific and medical experiments, the results of scientific and medical experiments and tests, the analysis and evaluation of scientific and medical data, and data generated by scientific and medical experiments and tests; genetic research; scientific and medical research and development services; custom design and development of biochemical assays; genetic engineering services; scientific research in the field of genetics and genetic engineering; scientific research relating to genetics; chemistry services, namely, chemistry research services; research relating to chemistry; scientific research relating to chemistry; research in the field of chemistry; molecular diagnostics testing
Medical services; human healthcare services; medical testing services relating to the diagnosis and treatment of disease; genetic testing for medical purposes; medical and health services relating to dna, genetics and genetic testing; medical diagnostic services in the nature of medical testing and medical analysis; providing collected and analysed medical information in the field of genetic and treatment information for diseases and disorders for diagnostic and treatment purposes; medical diagnostic imaging and molecular medicine services
No 79276870
No Service Mark
No T-4576 US MP
No
No
No
No
No
No
No
No
26.01.29 -
Helixes
The mark consists of the following: the wording "SpeeDx" with the wording in black except for one diagonal line of the letter "X" which is blue. A stylized DNA strand of blue and purple is to the left of the wording. White is used for the background but is not claimed as a feature of the mark.
| Status Date | Action Taken |
|---|---|
| 13th Aug 2021 | CHANGE OF NAME/ADDRESS REC'D FROM IB |
| 12th Apr 2021 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| 18th Mar 2021 | FINAL DISPOSITION PROCESSED |
| 18th Mar 2021 | FINAL DISPOSITION NOTICE SENT TO IB |
| 15th Mar 2021 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| 15th Dec 2020 | REGISTERED-PRINCIPAL REGISTER |
| 17th Nov 2020 | CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED |
| 17th Nov 2020 | ASSIGNED TO PETITION STAFF |
| 30th Oct 2020 | TEAS POST PUBLICATION AMENDMENT RECEIVED |
| 29th Sep 2020 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
